Document type
ArticleVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/119964
Marrow aplasia during high dose mebendazole treatment
Journal Title
Director/Tutor
Additional contribution
Journal ISSN
Volume Title
Abstract
A patient with chronic liver disease was treated with large doses of mebendazole for a hepatic hydatid cyst. Eighteen days after beginning treatment he developed marrow aplasia which reverted to normal after the drug was stopped. This is the sixth patient described as developing marrow aplasia when treated with large doses of mebendazole. We suggest that the aplasia is related to the dose of the drug, and that the patient's chronic liver disease was an important factor in its genesis. Patients treated with large doses of mebendazole should have their blood counts monitored during treatment.
Related resource
Subject
Subject (English)
Citation
Citation
FERNÁNDEZ BAÑARES, Fernando, et al. Marrow aplasia during high dose mebendazole treatment. American Journal of Tropical Medicine and Hygiene. 1986. Vol. 35, num. 2, pags. 350-351. ISSN 0002-9637. [consulted: 13 of October of 2026]. Available at: https://hdl.handle.net/2445/119964